Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

This publication has 24 references indexed in Scilit:

• Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
  The Lancet, 2011
• Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
  The Lancet Oncology, 2010
• Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
  JNCI Journal of the National Cancer Institute, 2010
• Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
  Published by Elsevier ,2009
• Health and Economic Implications of HPV Vaccination in the United States
  New England Journal of Medicine, 2008
• Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland
  British Journal of Cancer, 2007
• Highly Effective Detection of Human Papillomavirus 16 and 18 DNA by a Testing Algorithm Combining Broad-Spectrum and Type-Specific PCR
  Journal of Clinical Microbiology, 2006
• Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries
  Cancer Epidemiology, Biomarkers & Prevention, 2005
• A Longitudinal Study of Genital Human Papillomavirus Infection in a Cohort of Closely Followed Adolescent Women
  The Journal of Infectious Diseases, 2005
• TRENDS IN MORTALITY FROM CERVICAL CANCER IN THE NORDIC COUNTRIES: ASSOCIATION WITH ORGANISED SCREENING PROGRAMMES
  The Lancet, 1987